INVICTUS ANNOUNCES CHANGE TO MANAGEMENT AND BOARD
May 31 2019 - 5:30PM
Vancouver, BC, May 31, 2019 - INVICTUS MD STRATEGIES CORP.
("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA:
8IS2) announces that the Board of Directors (the
“Board”) has accepted Mr. George E. Kveton’s resignation as
Chief Executive Officer (“CEO”) of the Company and Mr.
Trevor Dixon, a member of the Board, will be assuming the role of
CEO.
“I am proud to be serving as the Company’s CEO,” said Mr. Dixon.
“I am committed to the long term and ongoing success of the
Company as we work to improve production, increase revenue and
decrease the cost of operations. With my thirty-five years
experience of founding, developing and operating successful
companies, I am confident I can further Invictus’ presence in the
cannabis industry,” Mr. Dixon continued, “as a significant
shareholder of the Corporation, I am dedicated to generating value
for the Company’s investors.”
Mr. Dixon was appointed a Director and Chief Operating Officer
of the Company on May 9th, 2019, and he also served as a Director
of the Company from April 2017 to January 2019. Mr. Dixon
remains founder, President and CEO of the Company’s wholly owned
subsidiary Acreage Pharms Ltd. (“Acreage Pharms”).
Assuming the role of CEO, Mr. Dixon brings more than seven years’
of knowledge inventing and creating systems for the production of
quality cannabis. Prior to this, Mr. Dixon developed
marketing systems, strategy and product development for an
international franchise business that he founded and eventually
sold after nineteen successful years of ownership. He also
pursued municipal politics for five years. It was during his
time in politics that he discovered the proposed new legislation on
the then Access to Cannabis for Medical Purposes Regulations and
immediately recognized the value of a complete seed to sale
business and founded Acreage Pharms in 2013. Today, Acreage
Pharms supplies recreational cannabis to British Columbia, Alberta,
Saskatchewan and Ontario and is approved to supply medical cannabis
to clients in all provinces in Canada.
“Mr. Dixon’s success with Acreage Pharms and his focused
leadership will help Invictus reach the next level with production
scaling being his top priority as he works to increase
collaboration across Invictus’ subsidiaries to maximize their
potential,” said Paul Sparkes, Chairman of the Board of
Invictus.
Mr. Kveton has worked to ensure a smooth transition for Mr.
Dixon in his new role and said, “It has been a great privilege to
have stewarded Invictus during an important period of
transformation. I strongly believe that the fabric of the Company
is strong, made up of experienced Board members and many talented
employees across all levels and provinces.”
Mr. Sparkes stated, “On behalf of the Board, we wish to thank
George for his valued leadership and for implementing the
difficult, but necessary changes to put the Company on the right
performance track. We wish him all the best.”
On Behalf of the Board, Paul Sparkes
Chairman of the Board connect@invictus-md.com Investor Relations
1-844-800-6086
Neither the TSX Venture Exchange nor its Regulation
Services Provider accepts responsibility for the adequacy or
accuracy of this release.
Kathy Love
Invictus MD Strategies Corp.
kathy@invictus-md.com
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Apr 2023 to Apr 2024